Bladder Cancer Market Size, Share, Growth, Analysis and Forecast 2023-2030

The global bladder cancer market is projected to grow at a considerable CAGR of 5.2% during the forecast period. The main cause of bladder cancer includes the consumption of tobacco products includes cigarettes, cigars, pipes, chewing tobacco. Moreover, extensive exposure to chemicals, past harmful radiation exposure, and parasitic infections are other factors that contributing to the growth of the market. Additionally, having a family history of bladder cancer, having certain changes in the genes that are linked to bladder cancer, and Past treatment with radiation therapy or certain anticancer drugs, such as cyclophosphamide or ifosfamide. The increasing prevalence of smoking and tobacco consumption has a major impact on the growth of the bladder cancer market across the globe. Changing the lifestyle of people is a significant cause of bladder cancer. Unhealthy eating activity is increasing among people, which is a major risk for bladder cancer. As per the American Lung Association, the average smoker smokes 15 cigarettes per day in the US. Similar trends can be observed in other countries of Europe and China, and Australia.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bladder-cancer-market

As per World Health Organization (WHO), there are 1.1 billion people consume tobacco across the globe. Smokers are 4 to 7 times more likely to develop bladder cancer than non-smokers. Bladder cancer is the tenth most common cancer across the globe. In 2018, there were 17 million new cases of bladder cancer across the globe. As per Cancer Research UK, the incidence of cancer is estimated to reach 62% during 2018-2040 across the globe. Bladder cancer is considered the fourth common cancer in men whereas it is the least common cancer in women. As per the American Cancer Society, there will be an estimated 80,470 new cases in the US in 2019. Out of this, 61,700 new cases will be associated with male and 18,770 will be associated with the female. For instance, in March 2016 the National Cancer Institute has invested $5.5 million in establishing laboratories to advance research on biomarkers and biomarker assays for several cancers. Market players can engage with these organizations so as expand their product offerings in the coming years.

Market Coverage

The market number available for - 2021-2027
Base year- 2020
Forecast period- 2021-2027
Segment Covered-
o By Cancer type

o By Diagnosis Method

o By Therapy

Regions Covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Bladder Cancer Market Report Segment

By Cancer type

Transitional Cell Bladder Cancer/ Urothelial Carcinoma
Squamous Cell Bladder Cancer
Adenocarcinoma
Other Rare Types (Sarcomas, Carcinoma in Situ)

By Diagnosis Method

Cystoscopy
Biopsy
Urinalysis
Urine Cytology
Intravenous Pyelogram (Ivp)
Other

By Therapy

Chemotherapy
Immunotherapy
Radiation Therapy
Surgery
Other

A full report of Bladder Cancer Market is available at: https://www.omrglobal.com/industry-reports/bladder-cancer-market

Bladder Cancer Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

AstraZeneca PLC
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly And Co.
Endo International Plc
Epocrates, Inc.
GlaxoSmithKline Plc
Hoffmann-La Roche Ltd.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Merck KGaA
Novartis International AG
Nucleix Ltd.
Pfizer Inc.
Spectrum Pharmaceuticals, Inc.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.